Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT.
Sureda A, Genadieva Stavrik S, Boumendil A, Finel H, Khvedelidze I, Dietricht S, Dreger P, Hermine O, Kyriakou C, Robinson S, Schmitz N, Schouten HC, Tanase A, Montoto S. Sureda A, et al. Among authors: khvedelidze i. Bone Marrow Transplant. 2020 Nov;55(11):2170-2179. doi: 10.1038/s41409-020-0929-y. Epub 2020 May 15. Bone Marrow Transplant. 2020. PMID: 32415225
Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT.
Martínez C, Boumendil A, Romejko-Jarosinska J, Anagnostopoulos A, Faber E, Poiré X, Yakoub-Agha I, Akhtar S, Gurman G, Pavone V, Halaburda K, Sousa AB, Ghesquières H, Finel H, Khvedelidze I, Montoto S, Sureda A. Martínez C, et al. Among authors: khvedelidze i. Leuk Lymphoma. 2020 Dec;61(12):2915-2922. doi: 10.1080/10428194.2020.1789624. Epub 2020 Jul 11. Leuk Lymphoma. 2020. PMID: 32654552
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMT.
Bento L, Boumendil A, Finel H, Khvedelidze I, Blaise D, Fegueux N, Castagna L, Forcade E, Chevallier P, Mordini N, Brice P, Deconinck E, Gramatzki M, Corradini P, Hunault M, Musso M, Tsoulkani A, Caballero D, Nati S, Montoto S, Sureda A; Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bento L, et al. Among authors: khvedelidze i. Bone Marrow Transplant. 2021 Mar;56(3):655-663. doi: 10.1038/s41409-020-01075-y. Epub 2020 Oct 12. Bone Marrow Transplant. 2021. PMID: 33046830
The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years.
Bazarbachi A, Boumendil A, Finel H, Khvedelidze I, Romejko-Jarosinska J, Tanase A, Akhtar S, Ben Othman T, Ma'koseh M, Afanasyev B, Cheikh J, Briones J, Gülbas Z, Hamladji RM, Elverdi T, Blaise D, Martínez C, Alma E, Halaburda K, Sousa AB, Glass B, Robinson S, Montoto S, Sureda A. Bazarbachi A, et al. Among authors: khvedelidze i. Leukemia. 2022 Jun;36(6):1646-1653. doi: 10.1038/s41375-022-01563-8. Epub 2022 Apr 12. Leukemia. 2022. PMID: 35414657
Correction: The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years.
Bazarbachi A, Boumendil A, Finel H, Khvedelidze I, Romejko-Jarosinska J, Tanase A, Akhtar S, Ben Othman T, Ma'koseh M, Afanasyev B, El-Cheikh J, Briones J, Gülbas Z, Hamladji RM, Elverdi T, Blaise D, Martínez C, Alma E, Halaburda K, Sousa AB, Glass B, Robinson S, Montoto S, Sureda A. Bazarbachi A, et al. Among authors: khvedelidze i. Leukemia. 2022 Aug;36(8):2150. doi: 10.1038/s41375-022-01639-5. Leukemia. 2022. PMID: 35840758 No abstract available.